---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-21-024532"
form_type: "8-K"
ticker: "LMAT"
cik: "0001158895"
company_name: "LEMAITRE VASCULAR INC"
filed_at: "2021-10-28T23:59:59+00:00"
generated_at: "2026-06-28T16:35:41.251217+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# LeMaitre Q3 sales $38.4M (+5% organic), EPS $0.30 (-19%), declares $0.11 dividend

## Summary
- Net income $6.5M (-13%), op. income $9.1M (-9%), gross margin 64.8% (+250 bps).
- Cash & investments $67.1M after $58.7M stock offering; Artegraft debt paid off.
- Q4 guidance: sales $39–41M (midpoint +7%), EPS $0.29–0.34 (-8% midpoint).
- Quarterly dividend $0.11/share, payable Dec 2 to holders of record Nov 19.
- Americas and EMEA grew 5% each, APAC up 16%; Delta variant deferred elective surgeries.

## SEC filing metadata
- accession: 0001437749-21-024532
- form_type: 8-K
- ticker: LMAT
- cik: 0001158895
- company_name: LEMAITRE VASCULAR INC
- filed_at: 2021-10-28T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1158895/000143774921024532/0001437749-21-024532-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1158895/000143774921024532/lmat20211028_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-21-024532
- JSON: https://secwatch.observer/filing/0001437749-21-024532.json
- Plain text: https://secwatch.observer/filing/0001437749-21-024532.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.